BiPar Sciences, Inc.
BiPar Sciences, Inc. is named on 0 US grants and 5 published applications in this corpus. Its most frequent classification is A61K (Medicines and medical preparations).
- Granted patents
- 0
- Published applications
- 5
- Inventors
- 9
- Granted in 2026 so far
- 0
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2007 | 0 | 1 |
| 2008 | 0 | 1 |
| 2009 | 0 | 3 |
By publication year.
Technology areas
Share of 5 documents
Recent patents
No granted patents yet.
- Treatment of cancer with combinations of topoisomerase inhibitors and parp inhibitors11 Jun 2009US 2009/0149397 A1
- Treatment of breast cancer with a parp inhibitor alone or in combination with anti-tumor agents21 May 2009US 2009/0131529 A1
- Treatment of uterine cancer and ovarian cancer with a parp inhibitor alone or in combination with anti-tumor agents14 May 2009US 2009/0123419 A1
- Treatment of Cancer25 Dec 2008US 2008/0319054 A1
- Treatment of Cancer18 Jan 2007US 2007/0015837 A1
Most cited
By later US patents
None of its patents has been cited by a later US patent yet.